Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer
- Steffan T. Nawrocki
- , Kevin R. Kelly
- , Peter G. Smith
- , Claudia M. Espitia
- , Anthony Possemato
- , Sean A. Beausoleil
- , Michael Milhollen
- , Stephen Blakemore
- , Michael Thomas
- , Allison Berger
- , Jennifer S. Carew
Research output: Contribution to journal › Article › peer-review
108
Link opens in a new tab
Scopus
citations